![Edward D. Wirth](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Edward D. Wirth
Nessuna posizione attualmente
Profilo
Edward D.
Wirth worked as the Chief Medical Officer at Asterias Biotherapeutics, Inc. from 2013 to 2019.
Prior to that, he was the Chief Science Officer at InVivo Therapeutics Corp.
in 2012, the Chief Medical Officer at Lineage Cell Therapeutics, Inc., and the Medical Director-Regenerative Medicine Division at Geron Corp.
from 2004 to 2011.
Wirth earned two doctorate degrees from the University of Florida in 1992 and 1994.
Precedenti posizioni note di Edward D. Wirth
| Società | Posizione | Fine |
|---|---|---|
| ASTERIAS BIOTHERAPEUTICS INC | Direttore Tecnico/Scientifico/R&S | 01/03/2019 |
InVivo Therapeutics Corp.
 InVivo Therapeutics Corp. BiotechnologyHealth Technology Develops groundbreaking technologies for the treatment of spinal cord injuries | Direttore Tecnico/Scientifico/R&S | 01/09/2012 |
| GERON CORPORATION | Corporate Officer/Principal | 01/10/2011 |
| LINEAGE CELL THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Edward D. Wirth
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
70
Relazioni di 1° grado
5
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
Lineage Cell Therapeutics, Inc.
 Lineage Cell Therapeutics, Inc. BiotechnologyHealth Technology Engages in research and development of therapeutic products for retinal & neurological diseases and disorders and oncology | Health Technology |
Geron Corp.
 Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
InVivo Therapeutics Corp.
InVivo Therapeutics Corp. BiotechnologyHealth Technology Develops groundbreaking technologies for the treatment of spinal cord injuries | Health Technology |
Asterias Biotherapeutics, Inc.
 Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops and commercializes regenerative medicine for neurology and oncology applications | Health Technology |
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
